The protective effect of catechin on gastric mucosal lesions in rats, and its hormonal mechanisms

Sato, Hideki; Matsui, Teruaki; Arakawa, Yasuyuki
February 2002
Journal of Gastroenterology;2002, Vol. 37 Issue 2, p106
Academic Journal
journal article
Background: Catechin, a polyphenol contained in tea (a cup of tea contains approximately 0.1% [w/v] catechin), has various physiological effects. The aim of this study was to investigate the mechanism of the inhibitory effect of catechin on gastric mucosal lesions.Methods: We studied the effect of catechin on gastric mucosal lesions in rats, using a water immersion restraint (WIR) stress-induced gastric mucosal lesion model. We used crude catechin that contained 52.6% (w/w) (-)-epigallocatechin gallate and 16.7% (w/w) (-)-epicatechin gallate. The rats were randomly divided into three groups; control rats freely drank distilled water, and the remaining rats drank 0.1% (w/v) or 1% (w/v) crude catechin-containing water for 2 weeks. We measured fractional areas of hemorrhagic erosion in the gastric mucosa induced by WIR stress for 4h, compared with findings in the controls. We also employed an isolated rat stomach infusion model and measured gastrin, somatostatin, and histamine in the perfusate to endocrinologically investigate the mechanism underlying the putative protective effect of catechin.Results: Catechin had a significant protective effect against the gastric mucosal lesions induced by WIR stress. Catechin also significantly inhibited the release of gastrin, somatostatin, and histamine.Conclusions: Catechin confers a protective effect against gastric mucosal lesions, and anti-gastric and anti-histaminergic effects may be involved in the mechanism of this effect.


Related Articles

  • Gastric mucosa-associated lymphoid tissue lymphomas: More than a fascinating model. Roggero, Enrico; Zucca, Emanuele // JNCI: Journal of the National Cancer Institute;09/17/97, Vol. 89 Issue 18, p1328 

    Editorial. Comments on the value of studies conducted concerning gastric mucosa-associated lymphoid tissue (MALT) lymphomas. Principal histologic feature; Duration of remission; Efficacy of antibiotics in inducing remission; Response to eradication of Helicobacter pylori.

  • Editor's quiz: GI snapshot.  // Gut;Mar2010, Vol. 59 Issue 3, p347 

    The article presents the answer on a quiz regarding the diagnosis on gastric submucosal mass, such as the confluent granulomatous inflammation showed in gastric mucosal biopsy with occasional acid-fast bacilli consistent with tuberculosis (TB).

  • Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms. Tu Luong; Emanuela Pilozzi; Italo Bearzi; Cesare Bordi // Virchows Archiv;Feb2008, Vol. 452 Issue 2, p169 

    Abstract  Two cases of gastric tumors showing mixed composition of endocrine cell clusters and exocrine glands and originally diagnosed as mixed neoplasms are described. In both cases, the exocrine glandular component was restricted to the upper third of the neoplasms being...

  • Wagner-Meissner–Like Corpuscles in Gastric Mucosa: A Brief Report. Reale, Domenico; Ballotta, Maria R.; Borghi, Laura; Lisato, Laura C.; Rasi, Annalisa; Menegatti, Maria T. // International Journal of Surgical Pathology;Sep2014, Vol. 22 Issue 6, p544 

    Wagner-Meissner corpuscles are touch receptors that are located in dermal papillae and are usually absent in gastrointestinal mucosa. Wagner-Meissner–like corpuscles have been reported in association with benign neural neoplasm. A case of Wagner-Meissner–like corpuscles in...

  • CHORISTOMA OF THE STOMACH. Abrams, Raymond M.; Pearlman, Alexander W. // American Journal of Gastroenterology;Feb1962, Vol. 37 Issue 2, p185 

    Presents a case study which focused on an unusual tumefaction in the wall of the stomach composed of microscopically normal ectopic tissues. Examination of the microscopic sections in the stomach; Information on choristoma; Indication of the presence of a miniature stomach in the tumor.

  • Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Kakiuchi, Miwako; Nishizawa, Takashi; Ueda, Hiroki; Gotoh, Kengo; Tanaka, Atsushi; Hayashi, Akimasa; Yamamoto, Shogo; Tatsuno, Kenji; Katoh, Hiroto; Watanabe, Yoshiaki; Ichimura, Takashi; Ushiku, Tetsuo; Funahashi, Shinichi; Tateishi, Keisuke; Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Koike, Kazuhiko; Seto, Yasuyuki; Fukayama, Masashi // Nature Genetics;Jun2014, Vol. 46 Issue 6, p583 

    Diffuse-type gastric carcinoma (DGC) is characterized by a highly malignant phenotype with prominent infiltration and stromal induction. We performed whole-exome sequencing on 30 DGC cases and found recurrent RHOA nonsynonymous mutations. With validation sequencing of an additional 57 cases,...

  • Pared gástrica en teratoma quístico benigno de ovario. Zaragoza Vargas, Perla Esther; Dickter, Sergio; Baquera Heredia, Javier; Ortiz Hidalgo, Carlos // Ginecologia y Obstetricia de Mexico;ene2007, Vol. 75 Issue 1, p43 

    We present the clinicopathlogical features of an ovarian mature cystic teratoma with a fully developed gastric wall containing an extensive peptic ulcer. Complete gastric wall, was the only teratomatous tissue present. There are only two previous reported cases of gastric mucosa with a peptic...

  • Cyclooxygenase-2 and P-glycoprotein expression in H. pylori-positive gastritis non responder to eradication therapy. Rocco, A.; Patrignani, P.; Perna, F.; Vaira, D.; Budillon, G. // Gut;Sep2002 Supplement 2, Vol. 51, pA40 

    The MDR1 P-glycoprotein (Pg-p) encoded by MDR1-gene is a member of multi-drug related protein. It is physiologically expressed in the mucosa of lower gastrointestinal tract. Overexpression of MDR1 Pg-p is often found in tumours related to resistance to chemotherapy. Cylooxygenase-2 (COX-2) is a...

  • Anti-Tumor Effects of Mfn2 in Gastric Cancer. Ge-Er Zhang; Hai-Long Jin; Xian-Ke Lin; Chao Chen; Xiao-Sun Liu; Qing Zhang; Ji-Ren Yu // International Journal of Molecular Sciences;Jul2013, Vol. 14 Issue 7, p13005 

    Mitofusin-2 (Mfn2) is a mitochondrial outer membrane protein involved in mitochondrial fusion. Its mutation can cause Charcot-Marie-Tooth disease. Recent studies of Mfn2 in cancer research have not included gastric cancer. We confirmed that Mfn2 expression was lower in tumor tissue than in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics